Famotidine Powder, For Solution
Product Images NDC 50383-913

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Famotidine (NDC 50383-913). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Akorn, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fam08 0000 01

Chemical structure diagram of famotidine, showing the arrangement of atoms including nitrogen, sulfur, carbon, and functional groups relevant to its molecular composition.*

FDA Label Image

Fam08 0000 02

Famotidine for Oral Suspension USP 40 mg/5 mL by Akorn, presented as a powder for solution in a carton label. The label shows the active ingredient strength of 400 mg per 50 mL after constitution, with each 5 mL containing 40 mg of famotidine. The carton includes instructions for constitution with purified water, storage conditions, inactive ingredients, manufacturer details, and a warning to shake well before use. The product is marked for prescription use only and not for injection.*

FDA Label Image

Fam08 0000 03

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.